Past Trainings

Why is it important for Decision Makers and Researchers to know how to use HEOR in Decision Making?

In Healthcare today, in every country, decision makers are asked to select from more than one “intervention” that may be used among other things in curing a patient, or alleviating their symptoms. However, the costs of these interventions range dramatically, and the benefits can be economic, clinical or both. To adequately compare and choose, one needs to be able to not only understand the underlying economic techniques to be able to perform analyses on their own, but also needs to critically evaluate the work of others. Lastly, one needs to know how to determine what the recommendation will be, what assumptions need to be made, and to explain the decision criteria, all in a format that can easily be understood by administrators, or government regulators, or clinician. This course setting allows one to learn these skills while interacting with other people with similar problems, but who come from different places and hence will provide participants with other perspectives to solving problems using healthcare economics they may not have previous considered.

Info and Resources

ISPOR Task Force Report: Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

How you’ll benefit:

  • Learn how to design, analyze and critique economic studies and outcomes research
  • Engage with renowned experts in the field and have your work critiqued by an expert after you return home.
  • Network with colleagues, collaborators, and clients.
  • Share research, ideas, and developments in an open, objective environment.
  • Advance your career by participating in an ISPOR In-Person Training Program.
  • Stay current on health economic guidelines and methodological issues.

Who should Attend:

  • Those who are required to critically assess the economic analyses of others
  • Those who need to design economic or outcomes studies to compare therapeutic alternatives
  • Those who need to develop economic models, relying on clinical literature or data bases
  • Those who need to use the results of economic and outcomes studies to make decisions.